Unraveling the Place of Small Molecules in theTreatment of Fistulizing Crohn’s Disease—A Systematic Review and Network Meta-Analysis

Publikation: Bidrag til tidsskriftKommentar/debatForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 144 KB, PDF-dokument

OriginalsprogEngelsk
Artikelnummerotad074
TidsskriftCrohn's and Colitis 360
Vol/bind5
Udgave nummer4
Antal sider2
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
M.A., D.N.R., and F.O.B report no conflicts of interest. J.B. reports grants and personal fees from AbbVie, grants and personal fees from Janssen-Cilag, personal fees from Celgene, grants and personal fees from MSD, personal fees from Pfizer, grants and personal fees from Takeda, grants and personal fees from Tillots Pharma, personal fees from Samsung Bioepis, grants, and personal fees from Bristol Myers Squibb, grants from Novo Nordisk, personal fees from Pharmacosmos, personal fees from Ferring, personal fees from Galapagos, outside the submitted work. J.B.S. has received research grants from Takeda, Janssen and is the national coordinator of studies from AbbVie, Arena Pharmaceuticals, Ely Lilly, and Boehringer Ingelheim. None of these pertain to the research submitted here.

ID: 387034961